-+ 0.00%
-+ 0.00%
-+ 0.00%

DocMorris Tightens FY26 Revenue Guidance

MT Newswires·11/12/2026 01:15:49
Listen to the news
01:15 AM EST, 11/12/2026 (MT Newswires) -- DocMorris (DOCM.SW) tightened its guidance for full-year 2026 revenue, according to a Thursday release. The Switzerland-listed online pharmacy company now expects revenue for the year to grow 15%, compared with previous expectations of an increase of 12.5% to 15%.